A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

keywords

  • ANTIEPILEPTIC DRUGS
  • FARNESYLTRANSFERASE INHIBITOR
  • Life Sciences & Biomedicine
  • Newly diagnosed glioblastoma
  • Oncology
  • PROTEIN TRANSFERASE INHIBITOR
  • RADIOTHERAPY
  • RAS
  • RECURRENT MALIGNANT GLIOMA
  • Radiation
  • Radiology, Nuclear Medicine & Medical Imaging
  • Tipifarnib

WoS ID

  • 000297602400031

end page

  • 1427

volume

  • 81

issue

  • 5